RAPSN and Diplopia: In a review of 10 patients with RAPSN mutations, it was suggested that diplopia without clear ophthalmoparesis could serve as a reliable criterion for differentiating rapsyn-CMS mutations from CMS caused by mutations affecting the number of AChR expressed in the NMJ [14].